Lai Lawrence P, Stitik Todd P, Foye Patrick M, Georgy John S, Patibanda Varun, Chen Boqing
Department of Physical Medicine and Rehabilitation, Rutgers, New Jersey Medical School, 90 Bergen St., Newark, NJ 07103(∗).
Department of Physical Medicine and Rehabilitation, Rutgers, New Jersey Medical School, Newark, NJ(†).
PM R. 2015 Jun;7(6):637-48. doi: 10.1016/j.pmrj.2015.02.003. Epub 2015 Feb 14.
To systematically analyze the literature on the use of platelet-rich plasma (PRP) for intra-articular injections of the knee and its efficacy in the treatment of knee osteoarthritis (OA).
Systematic literature reviews were conducted in PubMed, Embase, and CINAHL (ie, Cumulative Index to Nursing and Allied Health Literature) on October 30, 2013, using the keywords "platelet-rich plasma" and "knee" and "osteoarthritis." Inclusion criteria included (1) studies with human subjects, (2) prospective clinical studies (including either clinical trials or observational studies), and (3) full-text articles published in English. Exclusion criteria were: (1) animal studies; (2) retrospective studies; (3) patients with previous surgical intervention with total knee arthroplasty or reconstruction of the anterior cruciate ligaments; and (4) articles not published in English
A total of 319 abstracts and titles were reviewed (60 from PubMed, 250 from Embase, and 9 from CINAHL). A total of 8 relevant journal articles were identified, all of which were published between 2010 and 2013. One-half of the studies were prospective observational studies that included only PRP treatment; the rest were prospective comparative studies including both PRP and controls-2 were randomized controlled trials. Of the 4 comparative studies, 3 compared PRP with hyaluronic acid, which was considered as a commonly used effective treatment for knee OA; the other one used saline injection (ie, placebo) as the control. Although most of the analyses suffered from small sample size and was thus inconclusive, the findings consistently indicated that PRP might have better outcomes in patients with a lesser degree of degeneration and in younger patients.
PRP intra-articular injections of the knee may be an effective alternative treatment for knee OA. However, current studies are at best inconclusive regarding the efficacy of the PRP treatment. A large, multicenter randomized trial study is needed to further assess the efficacy of PRP treatment for patients with knee OA.
系统分析关于使用富血小板血浆(PRP)进行膝关节腔内注射及其治疗膝骨关节炎(OA)疗效的文献。
于2013年10月30日在PubMed、Embase和CINAHL(即护理及相关健康文献累积索引)数据库中进行系统文献综述,使用关键词“富血小板血浆”、“膝关节”和“骨关节炎”。纳入标准包括:(1)以人为研究对象的研究;(2)前瞻性临床研究(包括临床试验或观察性研究);(3)以英文发表的全文文章。排除标准为:(1)动物研究;(2)回顾性研究;(3)既往接受过全膝关节置换术或前交叉韧带重建手术干预的患者;(4)非英文发表的文章。
共检索了319篇摘要和标题(60篇来自PubMed,250篇来自Embase,9篇来自CINAHL)。共识别出8篇相关期刊文章,均发表于2010年至2013年之间。其中一半的研究为仅包含PRP治疗的前瞻性观察性研究;其余为包括PRP和对照的前瞻性比较研究,其中2项为随机对照试验。在4项比较研究中,3项将PRP与透明质酸进行比较,透明质酸被认为是治疗膝OA的常用有效疗法;另一项使用盐水注射(即安慰剂)作为对照。尽管大多数分析样本量较小,因此结果尚无定论,但研究结果一致表明,PRP可能在退变程度较轻的患者和年轻患者中具有更好的疗效。
膝关节腔内注射PRP可能是膝OA的一种有效替代治疗方法。然而,目前关于PRP治疗疗效的研究充其量尚无定论。需要开展一项大型、多中心随机试验研究,以进一步评估PRP治疗膝OA患者的疗效。